Monthly report · final

What Congress traded in September 2026

In September 2026, 39 members of Congress disclosed 748 trades in 46 filings: 337 buys, 401 sales and 10 exchanges.

The most-bought stock was $MSFT, bought by 3 members (up to $1.8M in all), and the largest single disclosed buy was Josh Gottheimer's $MSFT options, $500K–$1M. The best call since filing: Maria Elvira Salazar's buy of $MRNA, up 64.3% from the close on Sep 9, 2026, the day it was disclosed, to the close on Oct 29, 2026.

trades
748
members
39
buys
337
sales
401

Final: the filings made public Sep 1, 2026 to Sep 30, 2026. Last updated Oct 1, 2026.

Biggest disclosed buys

by the top of the disclosed range

Most-bought stocks

by how many members bought, then buys
  1. 1
    $MSFTMicrosoft
    3 members · 6 buys
    up to$1.8M
  2. 2
    $AVGOBroadcom
    3 members · 4 buys
    up to$95K
  3. 3
    $ACNAccenture
    3 members · 4 buys
    up to$60K
  4. 4
    $MRKMerck
    2 members · 4 buys
    up to$165K
  5. 5
    $MRVLMarvell Technology
    2 members · 4 buys
    up to$60K
  6. 6
    $BSXBoston Scientific
    2 members · 3 buys
    up to$45K
  7. 7
    $PEPPepsiCo
    2 members · 3 buys
    up to$45K
  8. 8
    $CRMSalesforce
    2 members · 2 buys
    up to$65K
  9. 9
    $ETNEaton
    2 members · 2 buys
    up to$65K
  10. 10
    $PWRQuanta Services
    2 members · 2 buys
    up to$65K

Most active members

by trades disclosed in the month
  1. Ro KhannaD· CA-17
    139 buys · 105 sales
    244
    trades
  2. Kevin HernR· OK-1
    14 buys · 109 sales
    125
    trades
  3. 70 buys · 48 sales
    119
    trades
  4. 19 buys · 57 sales
    76
    trades
  5. 24 buys · 9 sales
    33
    trades
  6. 9 buys · 8 sales
    17
    trades
  7. 6 buys · 6 sales
    12
    trades
  8. 7 buys · 5 sales
    12
    trades
  9. 7 buys · 4 sales
    11
    trades
  10. 5 buys · 4 sales
    9
    trades

Best calls since filing

the month's buys, by the stock's move to the close on Oct 29, 2026
  • $MRNA$1K–$15K(up to $15K)
    traded Aug 19, 2026filed Sep 9, 2026
    +64.3%
    since filed
  • Ro KhannaD· CA-17
    $MRNA$1K–$15K(up to $15K)
    traded Aug 24, 2026filed Sep 4, 2026
    +53.0%
    since filed
  • $ACN$1K–$15K(up to $15K)
    traded Jul 17, 2026filed Sep 4, 2026
    +32.4%
    since filed
  • Ro KhannaD· CA-17
    $ACN$1K–$15K(up to $15K)
    traded Aug 10, 2026filed Sep 4, 2026
    +32.4%
    since filed
  • $ACN$1K–$15K(up to $15K)
    traded Aug 26, 2026filed Sep 17, 2026
    +29.9%
    since filed
  • Ro KhannaD· CA-17
    $SNPS$1K–$15K(up to $15K)
    traded Aug 10, 2026filed Sep 4, 2026
    +24.5%
    since filed
  • $CRWD$1K–$15K(up to $15K)
    traded Jul 17, 2026filed Sep 4, 2026
    +22.5%
    since filed
  • Ro KhannaD· CA-17
    $ISRG$1K–$15K(up to $15K)
    traded Aug 24, 2026filed Sep 4, 2026
    +22.4%
    since filed
  • Ro KhannaD· CA-17
    $TXN$1K–$15K(up to $15K)
    traded Aug 3, 2026filed Sep 4, 2026
    +21.1%
    since filed
  • Ro KhannaD· CA-17
    $IT$1K–$15K(up to $15K)
    traded Aug 3, 2026filed Sep 4, 2026
    +20.7%
    since filed

Each move runs from the close on the day the trade was disclosed to the close on Oct 29, 2026.

By party and chamber

  • House · Democrats
    11 members · 476 trades
    250 buys · 223 sales
  • House · Republicans
    19 members · 210 trades
    54 buys · 150 sales
  • Senate · Democrats
    4 members · 46 trades
    25 buys · 21 sales
  • Senate · Republicans
    4 members · 15 trades
    8 buys · 6 sales
  • Senate · Independents
    1 member · 1 trade
    0 buys · 1 sale

Copy any member's portfolio

Copy the portfolio and your basket follows each new filing.

A month here is the trades disclosed in filings made public in it, not the trades made in it: members have up to 45 days to report a trade. Amounts are the ranges the filings disclose; "up to" is the top of a range, and a total adds the tops. Each trade counts once. The President and other executive-branch officials are not counted. Each member's page links every trade to its filing. This is a public record turned into a page, not a recommendation and not a statement about why anyone traded.